C₁₈H₂₁N₃O₃S (P274)
Quantities
| P4250 | defined daily dose | 20 |
| P2067 | mass | 359.13 |
| P3780 | active ingredient in | ... | Q47520876 (Aciphex) | Aciphex |
| P233 | canonical SMILES | String | CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC | ??? |
| P373 | Commons category | String | Rabeprazole | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P2175 | medical condition treated | ... | Q218712 (Zollinger–Ellison syndrome) | Zollinger–Ellison syndrome |
| P2175 | medical condition treated | ... | Q223591 (gastroesophageal reflux disease) | gastroesophageal reflux disease |
| P2175 | medical condition treated | ... | Q355170 (duodenal ulcer) | duodenal ulcer |
| P2175 | medical condition treated | ... | Q26695607 (peripheral vascular disease) | peripheral vascular disease |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P9989 | stylized name | String | RABEprazole | ??? |
| P279 | subclass of | ... | Q12140 (medication) | medication |
| P279 | subclass of | ... | Q174211 (organic compound) | organic compound |
| P2868 | subject has role | ... | Q421704 (proton-pump inhibitor) | proton-pump inhibitor |
| P2868 | subject has role | ... | Q41602594 (anti-ulcer drug) | anti-ulcer drug |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | rabeprazole | ??? |
Why not click here or view trends?
log id: None